Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.

导出 LinkOut

翻译打印收藏纠错

作者： Annika,Malmström ^[1] ; Hans Skovgaard,Poulsen ^[2] ; Bjørn Henning,Grønberg ^[3] ; Giuseppe,Stragliotto ^[4] ; Steinbjørn,Hansen ^[5] ; Thomas,Asklund ^[6] ; Birgitta,Holmlund ^[7] ; Małgorzata,Łysiak ^[8] ; Joseph,Dowsett ^[2] ; Bjarne Winther,Kristensen ^[9] ; Peter,Söderkvist ^[2] ; Johan,Rosell ^[10] ; Roger,Henriksson ^[10] ; Nordic Clinical Brain Tumor Study Group (NCBTSG) ^[2]

作者单位： a Department of Oncology , Linköping University Hospital , Linköping , Sweden. ^[1] b Department of Clinical and Experimental Medicine , Linköping University , Linköping , Sweden. ^[2] c Department of Oncology , Dept. 5073, Rigshospitalet , København Ø , Denmark. ^[3] d Department of Cancer Research and Molecular Medicine , NTNU, Norwegian University of Science and Technology , Trondheim , Norway. ^[4] e The Cancer Clinic, St. Olav's Hospital - Trondheim University Hospital , Trondheim , Norway. ^[5] f Department of Neurology , Karolinska University Hospital , Solna , Sweden. ^[6] g Department of Oncology , Odense University Hospital, University of Southern Denmark , Odense , Denmark. ^[7] h Department of Oncology , Radiumhemmet, Karolinska University Hospital , Solna , Sweden. ^[8] i Department of Oncology , Linköping University , Linköping , Sweden. ^[9] j Department of Pathology , Odense University Hospital, Institute of Clinical Research, University of Southern Denmark , Odense C , Denmark. ^[10] k Regional Cancer Center South East Sweden , Linköping , Sweden. ^[11] l Department of Radiation Sciences & Oncology , Umeå University , Umeå , Sweden. ^[12]